Haɓakawa da aikace-aikacen zaɓaɓɓun zoben rufewa na oxidative tare da ƙungiyoyin sulfhydryl da yawa

Binciken asali da kalubale

Zaɓin rufewar zobe na mahadi na sulfhydryl da yawa shine babban mataki a cikin haɗin haɗin sulfur mai ɗauke da heterocyclic., amma hanyar gargajiya tana da wadannan matsaloli:

• Ayyukan halayen sulfhydryl da yawa suna kama da juna, yana mai da wuya a cimma zaɓen sarrafawa. Yawancin halayen gefe, hadaddun kayayyakin, da wahalar keɓewa da tsarkakewa. Yanayin amsa yana da tsauri kuma iyakar aikace-aikacen yana da iyaka. Mun sami nasarar haɓaka sabuwar fasaha ta rufe zobe mai zaɓaɓɓu, wanda ke magance matsalolin da ke sama gaba ɗaya kuma yana samun ingantaccen aiki da daidaitaccen ɗaukar hoto.

Nasarar fasaha

• Sabbin tsarin iskar oxygenation: An gabatar da tsarin oxidation na tushen alkyne amide na farko, wanda ke inganta yawan zaɓi.
• Tsarin amsawa na musamman: ta hanyar wurare daban-daban na sulfhydryl substrate, an sami daidaitaccen rufewar zobe na sulfhydryl substrates da yawa.

Fa'idodin Fasaha

• Babban zaɓi: ainihin gano wuraren da aka yi niyya a tsakanin sulfhydryl substrates da yawa don cimma nasarar samar da samfur guda ɗaya.
• Babban inganci: yanayin halayen suna da laushi, kuma yawan amfanin da aka samu yana inganta sosai.
• Zaman duniya: m zuwa kira na daban-daban sulfur-dauke da heterocyclic mahadi.

Filin Aikace-aikace

• Haɗin magunguna: gina sulfur-dauke da heterocyclic kwayoyi kwayoyin (misali, thiophene, benzothiophene, dithiopyrrolidine, da dai sauransu.).
• Kayan aiki: shiri na sulfur-dauke da kayan polymer (misali. kayan gyaran kai, polymers masu gudanarwa, da dai sauransu.).
• Kimiyyar ilimin halitta: nazarin samuwar furotin da aikin haɗin gwiwar disulfide.

Xiaoxia Chen

Sabon Drug R&D Masanin fasaha Ƙwararrun Ƙwararru: Gano manufa, alakar tsarin-aiki (SAR) bincike, peptide-magungunan magunguna (PDCs), da kuma ci gaban anti-tsufa da kuma na rayuwa peptides.

Game da Marubuci Sabbin Labarai

Bayanan martaba: Xiaoxia Chen ta jagoranci binciken farko da bincike na gaskiya don yawancin magunguna na peptide na rayuwa da ƙari.. Ba wai kawai ta ƙware a cikin babban aikin tantance ɗakunan karatu na peptide ba amma kuma ta kware wajen yin amfani da ilimin lissafi na taimakon AI don ƙirar jerin jerin peptide.. A halin yanzu, tana jagorantar ƙungiyar da aka sadaukar don bincike mai zurfi da haɓaka agonists masu yawa na gaba-gaba (kamar dual- ko peptides masu rage kitse masu niyya sau uku) da kuma sosai aiki nama-gyara peptides.

• Yadda GLP-1 Oral ke sake rubuta Taƙaitaccen Ci gaban Peptide 2026年9月6日
• Abin da Generic GLP-1 Wave ke nufi don Sarkar Samar da Peptide 2026年9月6日
• GenScript ProBio Spin-Off: Jagoran Gudanarwa na CDMO mai siyan Peptide 2026年9月6日
• Peptides mai zane & Haɗin Kan Al'ada: Channel zuwa Neuro Scaffolds 2026年9月6日
• Abin da Kylo's GHK-Cu Launch ke nufi don Ingantaccen Reagent Peptide 2026年9月5日

An Duba Gaskiyar & Jagoran Edita

Tsarin Binciken Gaskiyar Mu

Muna ba da fifiko ga daidaito da mutunci a cikin abun cikin mu. Anan ga yadda muke kiyaye ma'auni masu girma:

1. Binciken Masana: Kwararrun batutuwan da suka shafi batun ne suke nazarin duk labaran.
2. Tabbatar da Tushen: Sahihanci yana goyan bayan bayanai, tushe na zamani.
3. Bayyana gaskiya: Muna ba da misalai a sarari kuma muna bayyana rikice-rikice masu yuwuwa.

Reviewed by: Kwararrun Maudu'i

Hukumar Binciken Mu

Our content is carefully reviewed by experienced professionals to ensure accuracy and relevance.

• Kwararrun Masana: ƙwararrun ƙwararru ne ke tantance kowane labarin da takamaiman ilimin filin.
• Fahimtar Sabuntawa: Muna haɗa sabon bincike, trends, da ma'auni.
• Alƙawarin zuwa Quality: Masu dubawa suna tabbatar da tsabta, daidaito, da cikawa.

Nemo lakabin da ƙwararru suka yi bita don karanta abun ciki da za ku iya amincewa.